The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Data From the International Pediatric Registry SWEET
Abstract
OBJECTIVE: Insulin delivery methods, glucose-monitoring modalities, and related outcomes were examined in a large, international, diverse cohort of children and adolescents with type 1 diabetes from the Better Control in Pediatric and Adolescent Diabetes: Working to Create Centers of Reference (SWEET) -Registry. RESEARCH DESIGN AND METHODS: Participants with type 1 diabetes of ≥1 year, aged ≤18 years, and who had documented pump or sensor usage during the period August 2017–July 2019 were stratified into four categories: injections–no sensor (referent); injections + sensor; pump–no sensor; and pump + sensor. HbA1c and proportion of patients with diabetic ketoacidosis (DKA) or severe hypoglycemia (SH) were analyzed; linear and logistic regression models adjusted for demographics, region, and gross domestic product per capita were applied. RESULTS: Data of 25,654 participants were analyzed. The proportions of participants (adjusted HbA1c data) by study group were as follows: injections–no sensor group, 37.44% (8.72; 95% CI 8.68–8.75); injections + sensor group, 14.98% (8.30; 95% CI 8.25–8.35); pump–no sensor group, 17.22% (8.07; 95% CI 8.03–8.12); and pump + sensor group, 30.35% (7.81; 95% CI 7.77–7.84). HbA1c was lower in all categories of participants who used a pump and/or sensor compared with the injections–no sensor treatment method (P < 0.001). The proportion of DKA episodes was lower in participants in the pump + sensor (1.98%; 95% CI 1.64–2.48; P < 0.001) and the pump–no sensor (2.02%; 95% CI 1.64–2.48; P < 0.05) groups when compared with those in the injections–no sensor group (2.91%; 95% CI 2.59–3.31). The proportion of participants experiencing SH was lower in pump–no sensor group (1.10%; 95% CI 0.85–1.43; P < 0.001) but higher in the injections + sensor group (4.25%; 95% CI 3.65–4.95; P < 0.001) compared with the injections–no sensor group (2.35%; 95% CI 2.04–2.71). CONCLUSIONS: Lower HbA1c and fewer DKA episodes were observed in participants using either a pump or continuous glucose monitoring (CGM) or both. Pump use was associated with a lower rate of SH. Across SWEET centers, use of pumps and CGM is increasing. The concomitant use of pump and CGM was associated with an additive benefit.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In comparisons of regimens of MDI with BGM (without CGM) vs CSII for T1D, there have been small improvements in A1C, but substantial reductions in severe and nocturnal hypoglycemia.1113,1125–1127”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1125]
In the citing paper
“Compared to capillary blood glucose monitoring, real-time continuous glucose monitoring has been shown to consistently improve glycaemic metrics in children,14 adolescents15 and adults,16 including older adults,17 with type 1 diabetes.”
From Blood glucose monitoring devices: current considerations (2023) · cites this paper as [14]
In the citing paper
“Besides advantages in increasing comfort, for example by enabling uninterrupted physical activity and minimizing the need for capillary glucose tests, better glycemic control has been shown in several studies. 7 , 13 , 19 , 20 , 21”
In the citing paper
“However, studies have shown mixed results regarding DKA incidence rates when comparing CSII with MDI. CSII has been associated with higher, 10 , 11 lower, 7 , 8 or practically equal 12 , 13 DKA incidence rates compared with MDI in various populations.”
In the citing paper
“CGM has been associated with lower frequencies of DKA in several international studies. 7”
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
Wolfsdorf, J. I., Glaser, N., Agus, M., Fritsch, M., Hanas, R., Rewers, A., Sperling, M. A., & Codner, E. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12701 · Cited by 710
DiMeglio, L. A., Acerini, C. L., Codner, E., Craig, M. E., Hofer, S. E., Pillay, K., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12737 · Cited by 604
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541
Karges, B., Schwandt, A., Heidtmann, B., Kordonouri, O., Binder, E., Schierloh, U., Boettcher, C., Kapellen, T., Rosenbauer, J., & Holl, R. W. (2017) · JAMA · doi:10.1001/jama.2017.13994 · Cited by 452
Self-citationMisso, M. L., Egberts, K. J., Page, M., O'Connor, D., & Shaw, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005103.pub2 · Cited by 406
Assessment and monitoring of glycemic control in children and adolescents with diabetes
Rewers, M. J., Pillay, K., de Beaufort, C., Craig, M. E., Hanas, R., Acerini, C. L., & Maahs, D. M. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12190 · Cited by 316
Šoupal, J., Petruželková, L., Grunberger, G., Hásková, A., Flekač, M., Matoulek, M., Mikeš, O., Pelcl, T., Škrha, J., Horová, E., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0888 · Cited by 242
for the T1D Exchange Clinic Network, T. D. I., Sherr, J. L., Hermann, J. M., Campbell, F., Foster, N. C., Hofer, S. E., Allgrove, J., Maahs, D. M., Kapellen, T. M., Holman, N., et al. (2016) · Diabetologia · doi:10.1007/s00125-015-3790-6 · Cited by 237
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Teplizumab and β-cell function in newly diagnosed type 1 diabetes
Ramos, E. L., Dayan, C. M., Chatenoud, L., Sumnik, Z., Simmons, K. M., Szypowska, A., Gitelman, S. E., Knecht, L. A., Niemoeller, E., Tian, W., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2308743 · Cited by 273
Arrieta, A., Battelino, T., Scaramuzza, A. E., Silva, J. D., Castañeda, J., Cordero, T. L., Shin, J., & Cohen, O. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14714 · Cited by 172
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery
Sherr, J. L., Schoelwer, M., Dos Santos, T. J., Reddy, L., Biester, T., Galderisi, A., van Dyk, J. C., Hilliard, M. E., Berget, C., & DiMeglio, L. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13421 · Cited by 152
McCall, A. L., Lieb, D. C., Gianchandani, R. Y., MacMaster, H. W., Maynard, G. A., Murad, M. H., Seaquist, E. R., Wolfsdorf, J. I., Wright, R. F., & Wiercioch, W. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac596 · Cited by 146
Predictors of time in target glucose range in real‐world users of the MiniMed 780G system
Castañeda, J., Mathieu, C., Aanstoot, H., Arrieta, A., Silva, J. D., Shin, J., & Cohen, O. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14807 · Cited by 112
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring
Tauschmann, M., Forlenza, G. P., Hood, K. K., Cardona‐Hernandez, R., Giani, E., Hendrieckx, C., DeSalvo, D. J., Laffel, L. M., Saboo, B., Wheeler, B. J., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13451 · Cited by 137
Self-citationAbraham, M. B., Karges, B., Dovč, K., Naranjo, D. M., Arbeláez, A. M., Mbogo, J., Javelikar, G., Jones, T. W., & Mahmud, F. H. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13443 · Cited by 135
Johnson, S. R., Holmes-Walker, D. J., Chee, M., Earnest, A., & Jones, T. W. (2022) · Diabetes Care · doi:10.2337/dc21-1666 · Cited by 86
Passanisi, S., Piona, C. A., Salzano, G., Marigliano, M., Bombaci, B., Morandi, A., Alibrandi, A., Maffeis, C., & Lombardo, F. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0373 · Cited by 68
Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Gosmanov, A. R., Gosmanova, E. O., & Kitabchi, A. E. (2021) · Cited by 94
Tauschmann, M., Cardona‐Hernandez, R., DeSalvo, D. J., Hood, K. K., Лаптев, Д. Н., Olinder, A. L., Wheeler, B. J., & Smart, C. E. (2025) · Hormone Research in Paediatrics · doi:10.1159/000543156 · Cited by 82
Self-citationLimbert, C., Tinti, D., Malik, F. S., Kosteria, I., Messer, L. H., Jalaludin, M. Y., Benitez‐Aguirre, P., Biester, S., Corathers, S. D., von Sengbusch, S., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13417 · Cited by 69
Self-citationDovč, K., Lanzinger, S., Cardona‐Hernandez, R., Tauschmann, M., Marigliano, M., Cherubini, V., Preikša, R. T., Schierloh, U. H. E., Clapin, H. F., Aljaser, F., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.0077 · Cited by 56
Self-citationBurnside, M. J., Williman, J. A., Davies, H. M., Jefferies, C., Paul, R. G., Wheeler, B. J., Wiltshire, E. J., Anderson, Y. C., & de Bock, M. I. (2022) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2022.100644 · Cited by 63
Self-citationDanne, T., Limbert, C., Puig‐Domingo, M., Prato, S. D., Renard, É., Choudhary, P., & Seibold, A. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01114-x · Cited by 54
Danne, T., Lanzinger, S., de Bock, M. I., Rhodes, E. T., Alonso, G. T., Barat, P., Elhenawy, Y. I., Kershaw, M., Saboo, B., Pinto, M. S., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0110 · Cited by 41
Self-citationLavens, A., Nobels, F. R. E., Block, C. E. M. D., Oriot, P., Verhaegen, A. A., Chao, S., Casteels, K., Mouraux, T., Doggen, K., Mathieu, C., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0003 · Cited by 44
Current Management of Glycemia in Children with Type 1 Diabetes Mellitus
Sperling, M. A., & Laffel, L. M. (2022) · New England Journal of Medicine · doi:10.1056/nejmcp2112175 · Cited by 42
PAULEY, M. E., Tommerdahl, K. L., Snell‐Bergeon, J. K., & Forlenza, G. P. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01799-x · Cited by 46
Tanenbaum, M. L., & COMMISSARIAT, P. V. (2023) · Endocrine Connections · doi:10.1530/ec-23-0193 · Cited by 35
Blood Glucose Level Time Series Forecasting: Nested Deep Ensemble Learning Lag Fusion
Khadem, H., Nemat, H., Elliott, D., & Benaissa, M. (2023) · Bioengineering · doi:10.3390/bioengineering10040487 · Cited by 43
Jacobsen, L. M., Sherr, J. L., Considine, E. G., Chen, A., Peeling, S., Hulsmans, M., Charleer, S., Urazbayeva, M., Tosur, M., ALAMARIE, S. A., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00358-x · Cited by 34
Virmani, A., Brink, S. J., Middlehurst, A. C., Mohsin, F., Giraudo, F., Sarda, A., Ajmal, S., Oettingen, J. E. V., Pillay, K., Likitmaskul, S., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13456 · Cited by 42
Lomax, K. E., Taplin, C. E., Abraham, M. B., Smith, G. J., Haynes, A., Zomer, E., Ellis, K. L., Clapin, H. F., Zoungas, S., Jenkins, A. J., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1178958 · Cited by 34
Marigliano, M., Eckert, A. J., Guness, P. K., Herbst, A., Smart, C. E., Witsch, M., Maffeis, C., & SWEET Study Group (2021) · Pediatric Diabetes · doi:10.1111/pedi.13274 · Cited by 35
Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population
Alonso, G. T., Triolo, T. M., Aktürk, H. K., PAULEY, M. E., Sobczak, M., Forlenza, G. P., Sakamoto, C., Pyle, L. L., & Frohnert, B. I. (2023) · Diabetes Care · doi:10.2337/dc22-2121 · Cited by 29
Sawyer, A., Sobczak, M., Forlenza, G. P., & Alonso, G. T. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0471 · Cited by 32
Use of diabetes technology in children
Schoelwer, M. J., DeBoer, M. D., & Breton, M. D. (2024) · Diabetologia · doi:10.1007/s00125-024-06218-0 · Cited by 33
Howe, C. J., Morone, J. F., Hawkes, C. P., & Lipman, T. H. (2023) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106221145323 · Cited by 28
Seget, S., Rusak, E., Polańska, J., & Jarosz-Chobot, P. A. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0148 · Cited by 22
Benchmarking Diabetes Technology Use Among 21 U.S. Pediatric Diabetes Centers
Prahalad, P., Hardison, H., Odugbesan, O., Lyons, S. K., Alwazeer, M., Neyman, A., Miyazaki, B., Cossen, K., Hsieh, S., Eng, D. S., et al. (2023) · Clinical Diabetes · doi:10.2337/cd23-0052 · Cited by 24
Wersäll, J. H., Adolfsson, P., Forsander, G., & Hanas, R. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13377 · Cited by 21
Bratke, H., Margeirsdottir, H. D., Assmus, J., Njølstad, P. R., & Skrivarhaug, T. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01127-6 · Cited by 20
Self-citationDovč, K., Name, M. A. V., Bizjan, B. J., Rusak, E., Piona, C. A., Mutlu, G. Y., Mentink, R., Frontino, G., Macedoni, M., Ferreira, S., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14607 · Cited by 21
Self-citationDekker, P., Aanstoot, H., Sas, T., de Vries, M., Birnie, E., Mul, D., & Nefs, G. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0038 · Cited by 21
Urakami, T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030781 · Cited by 19
Observed Characteristics Associated with Diabetes Device Use Among Teens with Type 1 Diabetes
Chen, C. W., TINSLEY, L. J., Volkening, L. K., Anderson, B. J., & Laffel, L. M. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211050069 · Cited by 19
Bratke, H., Biringer, E., Ushakova, A., Margeirsdottir, H. D., Kummernes, S. J., Njølstad, P. R., & Skrivarhaug, T. (2024) · Diabetes Care · doi:10.2337/dc24-0086 · Cited by 23
Self-citationChoe, J., Won, S., Choe, Y., Park, S. H., Lee, Y. J., Lee, J. E., Lee, Y. A., Lim, H. H., Yoo, J. H., Lee, S. Y., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0274 · Cited by 19
Álvarez-Elías, A. C., Lou‐Meda, R., Exeni, R. A., Exantus, J., Felix, M. B., González-Camac, S., & Ferris, M. (2023) · Current Pediatrics Reports · doi:10.1007/s40124-023-00287-2 · Cited by 15
Prahalad, P., Schwandt, A., Besançon, S., Mohan, M., Obermannová, B., Kershaw, M., Bonfanti, R., Lyckå, A. P., Hanås, R., Casteels, K., et al. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13278 · Cited by 17
Self-citationBratina, N., Auzanneau, M., Birkebæk, N., de Beaufort, C. E., Cherubini, V., Craig, M. E., Dabelea, D., Dovč, K., Hofer, S. E., Holl, R. W., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13416 · Cited by 17
Self-citationGitelman, S. E., Simmons, K. M., Sherr, J. L., Leichter, S. B., Quattrin, T., Russell, W. E., Sunil, B., Willi, S. M., Knecht, L. A., Niemoeller, E., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06586-1 · Cited by 18
Chobot, A. P., Piona, C. A., Bombaci, B., Kamińska-Jackowiak, O., Mancioppi, V., & Passanisi, S. (2024) · Children · doi:10.3390/children11080907 · Cited by 14
Self-citationBatir, D. M., Ștefan, C. S., Boev, M., Gurău, G., Popa, G. V., Matei, M. N., Ursu, M., Nechita, A., & Maftei, N.-M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072144 · Cited by 14
100 Years of insulin: Lifesaver, immune target, and potential remedy for prevention
Ziegler, A., Danne, T., Daniel, C., & Bonifacio, E. E. (2021) · Med · doi:10.1016/j.medj.2021.08.003 · Cited by 14
Blood glucose monitoring devices: current considerations
Sly, B., & Taylor, J. (2023) · Australian Prescriber · doi:10.18773/austprescr.2023.013 · Cited by 11
Gangqiang, G., Chen, H., & Sun, H. (2024) · Journal of Clinical Nursing · doi:10.1111/jocn.17110 · Cited by 11
Immune Interventions at Onset of Type 1 Diabetes — Finally, a Bit of Hope
Ludvigsson, J. (2023) · New England Journal of Medicine · doi:10.1056/nejme2312091 · Cited by 10
Ding, Y., Zhang, W., Wu, X., Wei, T., Wang, X., Zheng, X., & Luo, S. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.1037261 · Cited by 13
Challenges of Wearable Biosensors and Ways to Overcome Them
Tarasov, S. E., Plekhanova, Y. V., Reshetilov, A., Melenkov, S., & Saltanov, I. (2026) · Biosensors · doi:10.3390/bios16030159 · Cited by 10
New therapies towards a better glycemic control in youths with type 1 diabetes
Cardona‐Hernandez, R., Dovč, K., Biester, T., Ekhlaspour, L., Macedoni, M., Tauschmann, M., & Mameli, C. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106882 · Cited by 13
Self-citationChronic Disease Management of Children Followed with Type 1 Diabetes Mellitus
Baysal, Ş. G., Çiftçi, N., Dündar, İ., Büyükavcı, M. A., Yağın, F. H., Çamtosun, E., Doğan, D. G., & Akıncı, A. (2023) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2023.2022-8-4 · Cited by 9
Estock, J. L., Codario, R. A., Keddem, S., Zupa, M. F., Rodriguez, K. L., & DiNardo, M. M. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0498 · Cited by 10
Availability and Accessibility of Diabetes-Related Technologies in IDF-MENA Region
Ghafoor, E., Masood, S. N., Belkhadir, J., Sultan, M. T. H., Sandid, M., Baqai, S. M., & Shegem, N. (2022) · Journal of Diabetology · doi:10.4103/jod.jod_117_22 · Cited by 9
Parent, child, and adolescent lived experience using the insulin-only iLet Bionic Pancreas
Howard, K. R., Garza, K. P., Feldman, M. A., & Weissberg-Benchell, J. A. (2024) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsae022 · Cited by 10
Szadkowska, A., Baranowska‐Jaźwiecka, A., Michalak, A., Jarosz-Chobot, P. A., Myśliwiec, M., Głowińska‐Olszewska, B., Szypowska, A., Nazim, J., Mazur, A., Szalecki, M., et al. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13250 · Cited by 15
Self-citationChobot, A. P., Lanzinger, S., Alkandari, H., Alonso, G. T., Blauensteiner, N., Coles, N., SANCTIS, L. D., Mul, D., Saboo, B., Smart, C. E., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110809 · Cited by 8
Self-citationPrice, J., Hawkins, J., Amante, D. J., James, R., & Haire-Joshu, D. L. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01561-3 · Cited by 8
The inflammatory path toward type 1 diabetes begins during pregnancy
Ahrens, A. P., Dias, R., Hyötyläinen, T., Orešič, M., Triplett, E. W., & Ludvigsson, J. (2026) · Nature Communications · doi:10.1038/s41467-025-67712-6 · Cited by 8
Marigliano, M., Lanzinger, S., Imane, Z., Barcala, C., SHAH, A. S., Svensson, J., Tsochev, Κ., Mazur, A., Galli‐Τsinopoulou, A., Ioacără, S., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111616 · Cited by 9
Self-citationKaushal, T., TINSLEY, L. J., Volkening, L. K., Ambler-Osborn, L., & Laffel, L. M. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0258 · Cited by 11
Dicks, J. H., McCann, L. J., Tolley, A., Barrell, A. M., Johnson, L., Kuhn, I. L., & Ford, J. A. (2025) · Pediatric Diabetes · doi:10.1155/pedi/8875203 · Cited by 10
Vandervelden, C. A., Lockee, B., Barnes, M. S., Tallon, E. M., Williams, D. D., Kahkoska, A. R., Sarteau, A. C., Patton, S. R., Sonabend, R., Kohlenberg, J. D., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0484 · Cited by 9
Hayek, A. A., Mashali, M. A., & Dawish, M. A. A. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01569-w · Cited by 7
Winter, T. C., Derraik, J. G. B., Jefferies, C., Hofman, P. L., Shand, J. A. D., Braatvedt, G. D., & Misra, S. L. (2024) · Pediatric Diabetes · doi:10.1155/2024/5893771 · Cited by 6
Self-citationA Qualitative Analysis of Provider-Level Barriers to Prescribing Diabetes Technology
Maizel, J. L., Walker, A., Walls, A., Pasquel, F., Haller, M. J., & Bruggeman, B. S. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/8873848 · Cited by 7
Demir, G., ÇUBUKCU, E., & AKCAY, N. (2022) · Turkish Journal of Diabetes and Obesity · doi:10.25048/tudod.1105407 · Cited by 5
DKA Prevention and Insulin Pumps: Lessons Learned From a Large Pediatric Pump Practice
Doyle, E. A., WEINZIMER, S. A., & Tamborlane, W. V. (2022) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106221125699 · Cited by 6
Overview of modern sensors for continuous glucose monitoring
Темиргалиевич, М. К., Прокопьев, М. В., & Ivanov, I. V. (2023) · Diabetes Mellitus · doi:10.14341/dm13043 · Cited by 8
Elbarbary, N. S., & Ismail, E. A. R. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112042 · Cited by 8
Santos, T. J. D., Rodrigues, T. D. C., Puñales, M. K., Arrais, R. F., & Kopacek, C. (2021) · Current Pediatrics Reports · doi:10.1007/s40124-021-00248-7 · Cited by 6
Continuous and Intermittent Glucose Monitoring in 2022
Dovč, K., Bode, B. W., & Battelino, T. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.2502 · Cited by 6
Yafi, M., Shah, A., & Vélez, K. (2023) · Translational Pediatrics · doi:10.21037/tp-23-145 · Cited by 5
Knopp, M. I., Leonard, R., Geers, W., Tellez, S., Vidonish, B., Muthuvel, G., Magella, B., Yayah Jones, N.-H., Espinoza, J., & Corathers, S. D. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251395034 · Cited by 4
Self-citationSchierloh, U. H. E., Aguayo, G., Schritz, A., Fichelle, M., Dias, C. D. M., Vaillant, M., Cohen, O., Gies, I., & de Beaufort, C. E. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.870916 · Cited by 4
Harvengt, A., Beckers, M., Boutsen, L., Costenoble, E., Brunelle, C., & Lysy, P. A. (2023) · Nutrients · doi:10.3390/nu15132957 · Cited by 4
Wagner, G., Zeiler, M. D., Karwautz, A. F. K., Schneider, A. E., Rami-Merhar, B. M., & Berger, G. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.809015 · Cited by 8
Ståhl, F. L., Hellman, J., & Ekelund, C. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251414976 · Cited by 4
Casas, R., Tompa, A., Åkesson, K., Teixeira, P. F., Lindqvist, A., & Ludvigsson, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010374 · Cited by 6
Sadder, F., & Nemer, M. (2025) · Pediatric Diabetes · doi:10.1155/pedi/3568243 · Cited by 3
Limbert, C., Lanzinger, S., de Beaufort, C. E., Iotova, V., Pélicand, J., Prieto, M., Schiaffini, R., Šumník, Z., & Pacaud, D. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110110 · Cited by 3
Adolescent ambivalence about diabetes technology—The Janus faces of automated care
Cameron, F. J., Arnold, M., & Gregory, J. W. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13423 · Cited by 4
Marigliano, M., Piona, C. A., Tomasselli, F., Maguolo, A., Morandi, A., & Maffeis, C. (2023) · Acta Diabetologica · doi:10.1007/s00592-022-02019-2 · Cited by 4
Also the parents of children with type 1 diabetes need psychological support
Ludvigsson, J. (2024) · Acta Paediatrica · doi:10.1111/apa.17188 · Cited by 4
Yordsudueam, N., Numsriskulrat, N., Lerdrassameethad, W., Paleekul, P., Jitchana, J., Laichuthai, N., & Sahakitrungruang, T. (2025) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2550096.048 · Cited by 2
Psychometric analysis of the cross-cultural Spanish version of the diabetes management questionnaire
Yoldi-Vergara, C., Donlo, I. C., Cardona‐Hernandez, R., Manterola, I. G., Gómez, M. T. R., Garcés, M. L., & Ramon‐Krauel, M. (2022) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2022.11.015 · Cited by 3
Self-citationAvailability of psychological care in pediatric diabetes centers – a real need?
Kamińska-Jackowiak, O., Malatyńska, A., Chobot, A. P., & Gajewska, K. A. (2023) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.5114/pedm.2023.126358 · Cited by 3
Self-citationContinuous and Intermittent Glucose Monitoring in 2023
Dovč, K., Bode, B. W., & Battelino, T. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.2502 · Cited by 3
Detection and intelligent optimization of blood glucose signals based on MXene-assisted sensors
Bai, M., Zhou, Y., & Deng, S. (2024) · International Journal of Electrochemical Science · doi:10.1016/j.ijoes.2024.100687 · Cited by 2
Type 1 diabetes in children: adulthood ahead
Лаптев, Д. Н. (2025) · Diabetes Mellitus · doi:10.14341/dm13252 · Cited by 3
Marigliano, M., Franceschi, R., Mozzillo, E., Tiberi, V., Marino, M., Boccolini, G., Wasniewska, M. G., Street, M. E., Licenziati, M. R., Bonfanti, R., et al. (2025) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-025-01854-7 · Cited by 2
Diabetes Technology and Therapy in the Pediatric Age Group
Maahs, D. M., Prahalad, P., Schweiger, D. Š., & Shalitin, S. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.2508 · Cited by 1
Electronic Health Data Categories
Cascini, F. (2025) · SpringerBriefs in public health · doi:10.1007/978-3-031-88497-9_1 · Cited by 1
Gea, I. L., Jabato, F. M., Jiménez, A. B. A., Jurado, A. L., Gómez‐Perea, A., Romero-Pérez, M. D. M., García, E. G., Mata, M. Á. S., Martínez-Moya, G., Momblán, J. J., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176243 · Cited by 2
Secular trends in HbA1c levels among children and adolescents with type 1 diabetes
Chou, J., Lin, C., Lin, S.-K. K., Lee, Y.-J., Huang, C.-Y., Kao, Y.-E., Yu, J.-C., & Ting, W. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1786897 · Cited by 1
Güner, T. A. (2026) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2026.08.063 · Cited by 1
COVID-19 („coronavirus disease 2019“) und Typ-1-Diabetes: Kinder: Risiko Ketoazidose
Danne, T., & Kordonouri, O. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00776-2 · Cited by 2
Evin, F., Tittel, S. R., Piccini, B., Cardona‐Hernandez, R., Mul, D., SHEANON, N. M., Berge, T. V. D., Neuman, V., Tauschmann, M., & Gökşen, D. (2023) · Pediatric Diabetes · doi:10.1155/2023/8837506 · Cited by 1
Self-citation
Metadata
- Authors
- Cardona-Hernandez, R., Schwandt, A., Alkandari, H., Bratke, H., Chobot, A., Coles, N., Corathers, S., Goksen, D., Goss, P., Imane, Z., Nagl, K., O’Riordan, S. M. P., & Jefferies, C.
- Affiliations
- Division of Pediatric Endocrinology, Hospital Sant Joan de Déu, Barcelona, Spain
- Universität Ulm (DE)
- Dasman Diabetes Institute (KW)
- Fonna Hospital Trust (NO)
- University of Opole (PL)
- Markham Stouffville Hospital (CA)
- Cincinnati Children's Hospital Medical Center (US)
- Faculty of Medicine, Pediatric Endocrinology and Diabetes, Ege University, İzmir, Turkey
- Team Diabetes, Geelong, Victoria, Australia
- Mohammed V University (MA)
- Medical University of Vienna (AT)
- Cork University Hospital (IE)
- Starship Children's Health (NZ)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-03-02
- Volume
- 44
- Issue
- 5
- Pages
- 1176-1184
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W3134137658
- Cited by
- 129
- References
- 42
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 20 · 2023: 30 · 2022: 26 · 2021: 17
- FWCI
- 17.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 1 diabetes, insulin pump therapy, continuous glucose monitoring, HbA1c, glycemic control, diabetic ketoacidosis, severe hypoglycemia, children and adolescents, insulin delivery method, diabetes complications, diabetes-related hospitalization
- MeSH terms
- Adolescent, Blood Glucose, Child, Diabetes Mellitus, Type 1, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Registries, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.